Comments on ‘Competing Designs for Drug Combination in Phase I Dose-Finding Clinical Trials’ by M-K. Riviere, F. Dubois, S. Zohar

Statistics in Medicine - United States
doi 10.1002/sim.6336
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

A Bayesian Dose-Finding Design for Drug Combination Clinical Trials Based on the Logistic Model

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2014English

Designs for Phase I Trials in Ordered Groups

Statistics in Medicine
EpidemiologyStatisticsProbability
2016English

Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2000English

Operating Characteristics of Restrictions on Skipping Dose Level for Adaptive Dose-Finding Method in Two-Agent Phase I Trials

Japanese Journal of Biometrics
2015English

Practical Designs for Phase I Combination Studies in Oncology

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2015English

Escalation Strategies for Combination Therapy Phase I Trials

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2012English

Choice of Starting Dose for Biopharmaceuticals in First-In-Human Phase I Cancer Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2015English

Practical Model-Based Dose Finding in Early-Phase Clinical Trials: Optimizing Tissue Plasminogen Activator Dose for Treatment of Ischemic Stroke in Children

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy